AK Medical Holdings Limited disclosed in its 28 May 2026 Next Day Disclosure Return that it repurchased 550,000 ordinary shares on 28 May at HKD 5.84 each, spending HKD 3.21 million. The shares are intended for cancellation and were acquired on the Hong Kong Stock Exchange under the authority granted by shareholders on 18 June 2025.

Including the latest transaction, AK Medical has bought back 9.10 million shares since the current mandate became effective, equivalent to 8.11 % of the 112.27 million shares authorised for repurchase and about 0.81 % of the company’s 1.12 billion issued shares (excluding treasury shares). All repurchased shares—detailed across 15 separate buy-back dates between 6 February and 28 May—remain outstanding pending formal cancellation, leaving the company’s issued share count unchanged at 1.12 billion as of 28 May 2026.

Based on the disclosed quantities and prices, total cash deployed for the 9.10 million shares amounts to approximately HKD 56.35 million, implying a volume-weighted average repurchase price of roughly HKD 6.19 per share.

Under Listing Rule 10.06(3)(a), AK Medical is subject to a moratorium on issuing new shares until 27 June 2026 following the latest on-market repurchase.